Financhill
Back

Relmada Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Sell
27

RLMD
Relmada Therapeutics

Last Price:
$0.36
Seasonality Move:
8.98%
Sell
37

LLY
Eli Lilly and

Last Price:
$768.11
Seasonality Move:
3.89%
Sell
27
Relmada Therapeutics (RLMD) is a Sell

Is Relmada Therapeutics a Buy, Sell or Hold?

  • The current Relmada Therapeutics [RLMD] share price is $0.36. The Score for RLMD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $767.76. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLMD Stock Price Chart

What is Relmada Therapeutics's stock price today?

  • The Relmada Therapeutics share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $767.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.

RLMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 17.01 Sell
Chaikin Money Flow: 36672 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.36 - 2.86) Sell
Bollinger Bands (100): (1.8 - 3.76) Sell

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.86 Sell
Relative Strength Index (14 RSI): 40.37 Sell
Chaikin Money Flow: -8957052 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (751.18 - 808.5) Sell
Bollinger Bands (100): (795.65 - 929.57) Sell

RLMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.37 Sell
20-day SMA: 1.29 Sell
50-day SMA: 2.53 Sell
200-day SMA: 3.35 Sell
8-day EMA: 0.47 Sell
20-day EMA: 1.12 Sell
50-day EMA: 2.06 Sell
200-day EMA: 3.13 Sell

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 776.89 Sell
20-day SMA: 789.47 Sell
50-day SMA: 821.6 Sell
200-day SMA: 837.76 Sell
8-day EMA: 775.9 Sell
20-day EMA: 787.21 Sell
50-day EMA: 814.16 Sell
200-day EMA: 807.66 Sell

Relmada Therapeutics Earnings Growth & RLMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.41 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.86 per share, and an increase next year of $9.47 per share.

Relmada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):